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Abstract
Purpose ‘Big data’ are accumulating in a multitude of
domains and offer novel opportunities for research. The
role of these resources in mental health investigations
remains relatively unexplored, although a number of
datasets are in use and supporting a range of projects. We
sought to review big data resources and their use in mental
health research to characterise applications to date and
consider directions for innovation in future.
Methods A narrative review.
Results Clear disparities were evident in geographic
regions covered and in the disorders and interventions
receiving most attention.
Discussion We discuss the strengths and weaknesses of
the use of different types of data and the challenges of big
data in general. Current research output from big data is
still predominantly determined by the information and
resources available and there is a need to reverse the sit-
uation so that big data platforms are more driven by the
needs of clinical services and service users.
Keywords Big data  Mental disorders  Epidemiology 
Electronic health records
Introduction
‘Big data’ resources for research have attracted increasing
interest across healthcare, but applications in mental health
have remained relatively limited to date. Big data challenges
are traditionally characterised as those of volume (size of
datasets), velocity (rapid, ‘real-time’ acquisition of data),
and variety (multiple sources and types), with ‘variability’
and ‘veracity’ more recently added to reflect the unreliability
of information arising from some sources [1]. There are
numerous examples of different sources of big data which
might be utilised for health research, including those derived
from large biological sample collections, complex investi-
gations (e.g. imaging), devices, and social media. With
growing accessibility to large volumes of data accumulating
in routine clinical practice following the shift of medical
records from paper to electronic formats, clinical notes are
also potential big data resources for researchers. There has
been a long history of using routine data in mental health
research, from the earliest studies of asylum records through
the growth of the ‘case register’ in the mid- to late twentieth
century. However, larger volumes of information are now
accumulating in electronic format than would have been
conceivable 20–30 years ago, which potentially transforms
data-based investigations. We feel that it is timely to review
the information resources being used for big data research,
their current scope and coverage, and the nature of the
research emerging.
Method
In a narrative literature review, we sought to ascertain and
collate studies where big data approaches had been used in
research on mental illness and treatment. Aiming at a
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representative rather than exhaustive list, the authors used
recent reviews [2–10] to extract names of projects to use as
key words for a Google Scholar search, adding also the
requirement for the terms ‘‘mental health’’ or ‘‘psychiat*’’
for non-specialist sources, restricted to those since 2009.
Where no relevant papers were returned, a simple web
search for the project was also carried out to check for
name changes and non-academic outputs. Forward biblio-
graphic searching was also carried out to identify papers
that had cited the reviews above, in an attempt to identify
more recent projects. The authors included projects that
demonstrated a reach in terms of massed healthcare data,
and papers that had used big data approaches for mental
health research. Our review was limited to English-lan-
guage papers, and quantitative and qualitative studies about
opinion regarding use of healthcare data were not included.
Information was extracted on the name of the project
(where given), the database used, the data sources for the
database, and the geographical setting. The studies them-
selves were categorised into disease- or medication-speci-
fic, or other topics.
Results
Data resources identified and their international distribu-
tion are summarised in Table 1. In all, we identified 84
examples of databases that had been used to provide big
data answers to mental health research questions, of which
24 are specific to mental health and related topics. Geo-
graphically, most data resources were found in the United
States, with few specific national resources identified out-
side North America and northern/western Europe. How-
ever, there were a number of examples found of
multinational and multi-continent collaborative resources,
centred mostly on neurodegenerative or neurodevelop-
mental disorders. What should also be evident from
Table 1 is the large number of databases being used for
mental health research which are not themselves specific to
mental health over and above any other specialty.
Distributions of identified reports by disorder and nature
of research are summarised in Table 2 with examples,
although it is important to bear in mind that percentages
refer to studies identified in this review which will not have
been exhaustive; they are included for illustrative purposes
and inferences regarding the total literature should be
appropriately circumspect. The disorders covered in the
papers we identified show that big data resources had been
used most commonly to research unipolar depression and
dementia, followed by schizophreniform and autism spec-
trum disorders, and relatively uncommon output on bipolar
disorder, substance use disorders and neurodevelopmental
disorders. For most disorders, the output was reasonably
equally split between epidemiological/aetiological research
and analyses of treatments and outcomes. The distributions
of medication-reporting publications are summarised in
Fig. 1 and indicate a predominant focus on antipsychotic
and antidepressant agents, with relatively few publications
on mood stabilisers or treatments for dementia. Specific
examples of papers on medication and other topics are
given in Table 3. Beyond medication profiles and safety,
there were a number of papers on suicide, service use and
user characteristics. Few of the research studies that we
found were directly focused on mental health policy, but
their findings often have important policy implications. A
more detailed narrative of the types of questions addressed
forms the focus for discussion of the topic.
Discussion
A wide variety of big data resources are emerging as
platforms for mental health research, and it is
inevitable that the characteristics of these resources will
shape the questions addressed, particularly data availabil-
ity. At one end, there are databases that take full clinical
data directly from the electronic health record (EHR) at
primary care or hospital level; some databases are popu-
lated from specific patient-level information provided by
health service staff for the process of research or surveil-
lance; some make secondary use of unmodified adminis-
trative data; some rely on patient report. Some studies
transcend boundaries by making use of massed service-
level data—such as the European Observatory of Health
Systems and Policies—or combine findings from different
databases—such as the Psychiatric Genomics Consortium.
We have sought in this review to provide a snapshot of big
data resources which are now becoming available for
clinical/epidemiological mental health research and the
way in which these have been used to date. It would be
difficult to guarantee comprehensiveness in coverage due
to limitations in our search methodology, the fast pace of
current development in this field, the under-acknowledge-
ment of the role of databases, and the nature of much of the
research (i.e. not published in peer-review/indexed jour-
nals). In addition, the data resources themselves do not
exist within tightly definable boundaries. For example:
general healthcare databases may contain mental health
relevant information but may not have been used for
research within this field; many biological databases might
be classifiable as ‘big data’ because of the density of
information contained; and there is no clear point at which
information from a large survey, or series of surveys, or
cohort study, becomes large and detailed enough to be
called ‘big data’. We have referenced resources that have
access to large numbers of individuals, and have sought to
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Table 1 Resources arranged geographically
Region/nation Database Mental
health
specific?
Description Example
publication
Middle East, Asia and Australasia
Middle East Clalit Health Services No National. Covers 55 % Israeli population Hammerman et al.
[77]
Israeli Psychiatric Case register Yes National. Secondary care psychiatry. Since 1950 Lichtenberg et al.
[78]
Far East Hong Kong Hospital Authority No Covers 95 % secondary care in HK Cheung et al. [79]
Seoul National University No Local secondary care Park et al. [80]
Taiwan National Health Insurance Database No National. Covers 96 % Taiwan population Chen et al. [81]
Australia Mental Health National Outcomes and Casemix Yes National. Secondary care psychiatry. Since 2003 Burgess et al. [47]
Western Australia admin No Regional (3.7 m people). Mental health sub-group. Up to
50 years data
Lawrence et al.
[82]
Multi-country
(Asia)
Pan-Asian SNP Consortium (HUGO) No Research database Ngamphiw et al.
[83]
Europe
Western
Europe
Asturias Cumulative Psychiatric Case Register
(RACPAS)
Yes Spain. Regional (1 m people). Secondary care
psychiatry
Bobes et al. [84]
Gmu¨nder ErsatzKasse (GEK) No Germany. National. Large health insurer (6 %
population, around 5 m people)
Sauer et al. [85]
German Research Network on Depression/
DGPPN-BADO
Yes BADO is national minimum data set for inpatient
psychiatry. Depression network from 10
heterogeneous hospitals
von Wolff et al.
[48]
Health Search Database No Italy. National. Primary care data (1.5 % population,
around 1 m people)
Sultana et al. [86]
Marseille/French National Health Insurance Fund No Regional. Prescription data Bocquier et al. [87]
Regensberg Hospital/DGPPN-BADO Yes Germany. Local. BADO is minimum data set from
psychiatric inpatients
Frick et al. [88]
South Verona Community-Based Mental Health
Service
Yes Italy. Local. Secondary care psychiatry. 25 years? of
data
Donisi et al. [89]
Zurich/Swiss psychiatric case register Yes Regional. Secondary care psychiatry. 25 years? of data Lay et al. [90]
United
Kingdom
Clinical Practice Research Data link (CPRD),
formerly General Practice Research Database
(GPRD)
No National sample primary care providers. Some data open
access (NIHR.ac.uk)
Margulis et al. [91]
Clinical Record Interactive Search (CRIS) Yes Local secondary care psychiatry. South London and
Maudsley Biomedical Research Centre (SLaM BRC)
Case Register. 200,000? people
Perera et al. [20]
Generation Scotland No Regional (Scotland). Research database. Family based
cohort
Fernandez-Pujals
et al. [92]
GRiST Yes Multiple locations, primary and secondary care
psychiatry. Mental health risk assessment software
Buckingham [50]
Public Health England Mental Health Dementia
and Neurology Intelligence Network
Yes Regional (England). 22 ‘indicators’ from mixed
administrative sources
Wilkinson et al.
[93]
QResearch GP database No National sample primary care providers. 600 practices,
around 12 m people
Coupland et al.
[94]
The Health Improvement Network (THIN) No National sample primary care providers. 10 m people,
broadly representative of population
Osborn et al. [36]
UK Biobank No National sample 500,000 volunteers. Research database Smith et al. [58]
Secure Anonymised Information Linkage (SAIL) No Linked data from a range of healthcare sources covering
Wales (population 3 m)
John et al. [95]
PsyCymru Yes An e-cohort of around 12,000 psychosis cases in Wales
linked to SAIL data
Lloyd et al. [96]
Scandinavia Danish Psychiatric Central Research Register Yes National. Secondary care psychiatry with extensive
national linkage
Munk-Jorgensen
and Ostergaard
[97]
deCODE Iceland No National opt-in commercial/research database Thorgeirsson et al.
[98]
Dutch National Survey in General Practice No National sample primary care providers Maas et al. [99]
Finnish Hospital Discharge Register No National. Inpatients. Linked to other national registers Haukka et al. [100]
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Table 1 continued
Region/nation Database Mental
health
specific?
Description Example
publication
Mid-Netherlands Psychiatric Care Register Yes Regional—Utrecht and surrounding areas, population
760 k. Secondary care psychiatry
Braam et al. [101]
Norwegian Patient Register Yes National. Secondary care psychiatry. Linked to other
national registers
Evensen et al.
[102]
Odense University Pharmaco-epidemiologic
Database
No Denmark. Local prescription database with linkage Hansen et al. [103]
Eastern
Europe
Hungarian National Health Insurance Fund No National. Prescription-with-indication database Katona et al. [104]
Multi-country
(Europe)
European Observatory on Health Systems and
Policies
No Health services. Produces country-based reports Dlouhy´ and Barta´k
[105]
European Prevention of Alzheimer’s Dementia
(EPAD) project
Yes A European Innovation Medicines Initiative Ritchie et al. [106]
European Autism Interventions Yes A European Innovation Medicines Initiative Murphy and
Spooren [107]
Nordic population-based prescription database No Pharmaco-epidemiology using databases from five
countries
Zoe¨ga et al. [108]
PROTECT-EU No Pharmaco-vigilence using databases in three countries Requena et al.
[109]
Refinement Yes Mental health services. Population data and service
inventory
Sfetcu et al. [56]
America
Canada Canadian Chronic Disease Surveillance System
(CCDSS)
Yes National. Will specifically monitor excess mortality in
people with psychiatric diagnosis
Lesage et al. [110]
Canadian Primary Care Sentinel Surveillance
Network
No National sample primary care providers Wong et al. [35]
OntarioMD No Regional, primary care providers Hwang et al. [111]
Ontario Mental Health Reporting System Yes Regional, based on interRAI MH dataset for psychiatric
inpatients
Perlman et al. [112]
Saskatchewan Health Databases No Regional, multisource. 25 years? of data Meng et al. [113]
USA 23andMe No National. Commercial genotyping database, self-report Tung et al. [114]
Agency for Healthcare Research and Quality
(AHRQ) Healthcare Cost and Utilisation Project
(HCUP)
No National sample hospital care providers. Databases and
software through Federal-State-Industry partnership
Smith et al. [115]
Alzheimer’s Disease Genetic Consortium Yes Distributed network of sample of healthcare providers McDavid et al.
[116]
CDC data surveillance systems, including national
ambulatory care survey
No National. A number of monitoring systems and surveys Olfson et al. [117]
Data QUEST No Sample of 15 primary care providers in five states Estiri et al. [118]
Electronic medical records and genomics network
(eMERGE)
No Distributed network of five leading academic medical
centres for biobanking, includes Alzheimer’s cohorts
Kho et al. [40]
Group Health Research Institute (GHRI) No Healthcare management organization (HMO). HMO
network member
Lin et al. [119]
Health Plan Employer Data and Information Set
(HEDIS)
No National. Set of performance measures used by most
health plans in USA. Managed by National Committee
for Quality Assurance (NCQA)
Clark et al. [120]
Informatics for integrating biology and the
bedside (i2b2)
No Local secondary care. Biobank affiliated with Harvard
Medical Schools
Perlis et al. [26]
U.S. Food and Drug Administration (FDA) Mini-
Sentinel, including Innovation in Medical
Evidence Development and Surveillance
(IMEDS)
No National (currently sample) medication-based database,
aiming to create active monitoring system
Raebel et al. [121]
Kaiser Permanente, including KP Research
Program on Genes, Environment and Health
(RGEH)
No Regional sample. HMO based in Northern California,
3.4 m insured
Young et al. [122]
Mayo Clinic No Local secondary care provider. Based in Minnesota, also
contributes to Olmsted County/Rochester projects
Sohn et al. [123]
MarketScan Research Database No National sample. Commercial claims and encounters
database from mix of providers
Watkins et al. [124]
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Table 1 continued
Region/nation Database Mental
health
specific?
Description Example
publication
Medicaid & Medicare data No National sample. Government reimbursed healthcare
activity. Data accessed through CMS.gov or a variety
of platforms, including MarketScan and HEDIS
Medicaid Medical
Directors
Learning
Network [125]
Mental Health Research Network at Health Care
Systems Research Network, formerly HMO
research network
No National sample. Distributed network of up to 17 HMOs
with virtual data warehouse. Potentially 11 m
population in 11 states
Ahmedani et al.
[126]
Multiparameter Intelligent Monitoring in
Intensive Care (MIMIC)
No Local critically ill. ICU patients in Massachesets
teaching hospitals
Ghassemi et al.
[127]
National Prescription Audit (NPA) and National
Disease and Therapeutic Index (NDTI)
No National sample. Commercial medication-focused
databases from IMS Institute for Healthcare
Informatics
Alexander et al.
[128]
New York Presbytarian No Local. Single hospital. 30 years? of data Melamed et al.
[129]
Palo Alto Medical Foundation (PAMF) No Regional. Single HMO. HMO network member Goyal et al. [130]
Partners Healthcare No Regional. Single HMO. Feeds into i2b2 Castro et al. [131]
PharMetrics Patient-Centric Database, now
merged with IMS databases
No National sample. Pharmacy and encounter data 14 m
people
Berger et al. [132]
Penn Longitudinal Database Yes Regional. Public mental health use (secondary care) in
Philadelphia. Also part of collaborative perinatal
project
Connolly Gibbons
et al. [133]
Shared Health Information Network (SHRINE) No Multiple sites. Secondary care. Collaboration between
Harvard and University of California hospitals
Kohane [134]
Scalable Partnering Network (SPAN) for
Comparative Effectiveness Research (CER)
No National sample. Project providing linkage between nine
HMOs and two community partners
Toh et al. [38]
Stanford Translational Research Integrated
Database Environment (STRIDE)
No Local. Data from healthcare provider. Data on 2 m
people since 1994
Raj et al. [135]
Texas Department of Criminal Justice No Local database of prisoners Baillargeon et al.
[136]
University of Michigan Health System data
warehouse
No Local secondary healthcare provider. Uses Electronic
Medical Record Search Engine (EMERSE)
Hanauer et al.
[137]
Vanderbilt University Biorepository—BioVU No Local secondary care provider. Genomics, select health
metrics and EHR
Crawford et al.
[138]
Veterans Affairs Database No National specialist provider for veterans. Provides
healthcare for aprox 14 m, has smaller biobank
Bauer et al. [139]
Multi-continent
Aetionomy Yes Neurodegenerative diseases. Under European Innovative
Medicines Initiative, aligned with EPAD in Europe
and GAP in North America
Hofmann-Apitius
et al. [140]
Asian Pharmacoepidemiology Network (AsPEN) No Eight cohorts in distributed network model: six
countries, four continents, 200 m people
Pratt et al. [141]
Enhancing NeuroImaging Genetics through Meta-
Analysis (ENIGMA)
Yes Sets of research cohorts. 70 institutions taking part Thompson et al.
[60]
Global Burden of Disease (GBD)/WHO mental
health survey
No Estimates of morbidity for 187 countries Whiteford et al.
[57]
Genetic Consortium for Anorexia Nervosa Yes Up to 30 datasets for GWAS Reichborn-
Kjennerud et al.
[142]
Health Care Quality Indicators (HCQI) for OECD
countries
No Comparative data on national health systems Moran and
Jacobs[143]
IMS Prescribing Insights database No Medication-based database. Presence in 30 countries Wong et al. [144]
Psychiatric Genomic Consortium Yes Has a number of working groups for specific disorders
and cross-disorder group
Cross-Disorder
Group of the
Psychiatric
Genomics [59]
International Genomics of Alzheimer’s Project (I-
GAP)
Yes Including existing genetic consortia and other cohorts Lambert et al.
[145]
Soc Psychiatry Psychiatr Epidemiol (2016) 51:1055–1072 1059
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provide examples that are broadly representative of
emerging information available. For example, we have
cited administrative data registries with linked death cer-
tification records to investigate mortality in mental disor-
ders, and we have described these as big data; however,
there is no qualitative difference between this and the
linkage of the large Norwegian HUNT survey of over
60,000 community residents to national data on mortality
and occupation-related outcomes [11, 12], which tends to
be described instead as a large cohort study rather than ‘big
data’. Similarly, this review did not attempt to cover large
cohort studies with an emphasis on original data collection
rather than reliant on administrative data (e.g. in a UK
context, cohorts such as ALSPAC, Whitehall, or the 1946,
1957 or 1970 birth cohorts)—whose boundaries with big
data are inevitably indistinct. Big data resources, thus, tend
to be defined by the challenges faced by the data and their
interpretation, as will now be described, rather than solely
by the size or complexity of a database.
Big data and the five V’s
Big data resources are often characterised by ‘Vs’: origi-
nally three (volume, velocity and variety), now five (adding
Table 1 continued
Region/nation Database Mental
health
specific?
Description Example
publication
Sequenced Treatment Alternatives to Relieve
Depression (STAR*D)
Yes Whilst this international study was not ‘‘big data’’, in
terms of using hybrid EHR and manual methods, it
develops techniques to be used for observational
research in big data
Garriock et al.
[146]
WHO Global Health Observatory Data Repository No Special topics covered, including mental health and
suicide
WHO [147]
Table 2 Example topics in papers discussing mental illness epidemiology, treatment and outcome
Disorder (% of papers) Descriptive epidemiology
and service use
Risk factors, comorbidities and
genetics
Treatment and
prognosis
Physical health,
pregnancy, mortality
All disorders (10 %) Manson [148]
Heggestadet al. [149]
Roque et al. [150]
Cross-Disorder Group of the
Psychiatric Genomics [59]
Donisi et al. [89] Perini et al. [151]
Lawrence et al. [82]
Severe mental illness (5 %) Lyalina et al. [152] Kyaga et al. [153]
Steinberg et al. [154]
Perlman et al.
[112]
Matheson et al. [155]
Wangel et al. [156]
Dementia (9 %) Knopman et al. [24]
Kosteniuk et al. [157]
Exalto et al. [158]
Lambert et al. [145]
van den Bussche
et al. [159]
Rait et al. [160]
Substance use disorder (2 %) Bonn-Miller et al. [161] Nesva˚g [162] Mark et al. [163]
Schizophrenia (6 %) Okkels et al. [164]
Evensen et al. [102]
Harper et al. [165] Stroup et al. [166] Gal et al. [167]
Vigod et al. [168]
Bipolar disorder (2 %) Castro et al. [169] Schaefer et al. [170] Hayes et al. [171] Lee and Lin [172]
Depressive disorders (11 %) Hoffmann et al. [173]
Wong et al. [35]
Hanauer et al. [137]
Ul-Haq et al. [174]
Morkem et al.
[34]
Musliner et al.
[175]
Lin et al. [119]
Anxiety and somatoform
disorders (2 %)
Walters et al. [75] Lacourt et al. [176] Sandelin et al.
[177]
Frayne et al. [178]
Eating disorders (1 %) Micali et al. [179] Reichborn-Kjennerudet al. [142]
Post-partum mental disorders
(2 %)
Polachek et al. [180] Goyal et al. [130]
Intellectual disabilities (1 %) Sprung et al. [181] Alexander et al. [182]
Autism/Autism Spectrum
Disorder (ASD) (6 %)
Kohane [134] Hsu et al. [183]
Clarke et al. [184]
Wong et al. [144]
Murphy and
Spooren [107]
Other neuro-developmental
disorders (4 %)
Sure´n et al. [185] Leivonen et al. [186] Hoffmannet al.
[187]
1060 Soc Psychiatry Psychiatr Epidemiol (2016) 51:1055–1072
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variability and veracity), but with the potential for further
expansion (e.g. visualisation and value: http://dataconomy.
com/seven-vs-big-data/). Taking the five V’s as the most
common current characterisation, it is worthwhile consid-
ering each in turn as it applies to the mental health relevant
databases described here:
1. The examples we identified exemplify ‘volume’ in the
large number of cases represented and, in many
instances, the quantity of information on each person
represented. This particularly applies to healthcare data
which are linked to high-compute biological datasets
(e.g. from ‘omics’ and imaging) and to those which
include the full electronic health record—i.e. which
contain both large case numbers and large amounts of
detail on each case. While small compared to many
‘big data’ resources, electronic health records represent
a step-change in volume compared to the administra-
tive databases previously relied on for analysis.
2. ‘Velocity’ may be a feature of electronic health records
databases if these accumulate in real time, although is
less relevant to static and/or periodically updated sets,
and depends on the way in which a database is used. At
the moment most research use has been observational,
using historic data extractions and therefore not
encountering the velocity challenge, even in ‘live’
(i.e. continually accumulating) databases. This will
change once interventions start being developed which
rely on real-time data feeds from health records, and
will be challenge not only for hardware (e.g. the
demands on central or local processing hubs) but also
for designing appropriately agile software to enable
such processing.
3. ‘Variety’ has also been less relevant to date because
most analyses are still focusing on relatively stereotyped
datasets drawn from original or derived structured
fields; however, this is changing with increasing interest
in natural language processing to derive information
from text—whether relatively simple information
extraction applications to render pre-defined constructs
available as structured fields, or more complex whole-
text analytics (e.g. investigating subtle changes in health
records text as a potential predictor of adverse events
such as suicidal behaviour https://slamtwigops.
0% 5% 10% 15% 20% 25% 30% 35%
General psychotropics
Dementia drugs
Antipsychotics
Mood stabilisers
Antidepressants
Anxiolytic / Hypnotics
Stimulents
Relative Numbers of Papers 
medication use safety and adverse effects
Fig. 1 The relative number of
papers found reporting on
different classes of medication
(57 papers on medication in
total)
Table 3 Examples of other topics appearing in multiple papers
Topic (% of papers) Example papers
Medication prescription 6 % Sultana et al. [86]
John et al. [95]
Abdullah-Koolmees et al.
[188]
Hartz et al. [189]
Medication safety and adverse drug
reactions 13 %
Chung et al. [190]
Eriksson et al. [191]
Castro et al. [131]
Medication safety in older adults Hwang et al. [111]
Huybrechts et al. [54]
Medication safety during pregnancy Hviid et al. [192]
Palmsten et al. [193]
Suicide and self-injury 5 % Stewart et al. [194]
Simon et al. [195]
Mental health admissions 4 % Frick et al. [88]
Bardach et al. [196]
Patient characteristics 4 % Koopmans et al. [197]
Oram et al. [198]
Mental Health Services Quality 3 % Moran and Jacobs [143]
Soc Psychiatry Psychiatr Epidemiol (2016) 51:1055–1072 1061
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wordpress.com/tag/e-host-it/). ‘Variety’ will also
become an increasingly relevant consideration as
health records databases begin to integrate with the
large-volume information generated by devices and
remote monitoring, as well as potentially from patient-
entered data—or example, when considering the dif-
ferences in wording used to describe the experience of
a disorder between a clinician writing in the health
record and someone with the condition contributing to
an online forum.
4. ‘Variability’ is used to describe the phenomenon of
data whose meaning is constantly changing. Within
health records, data fields clearly do change over time
in the way information is entered, although this is
generally at a pace which is manageable. Text fields in
health records may present more of a challenge, as
there are likely to be more rapid and less manageable
changes in the ways clinicians record information,
although this is likely to be negligible compared to the
rapid evolution in social media and the language used
there (and thus in any development of shared records
with the facility for accommodating patient-entered
information).
5. ‘Veracity’ is perhaps the most important challenge in
the use of any administrative database for research,
simply because source data have not generally been
collected with research in mind and thus it is important
to be aware of factors influencing the recording of
information or not, and the accuracy with which this is
carried out. The veracity challenge will be considered
later in this discussion, having first reviewed the data
resources available.
Electronic health records
EHRs present novel opportunities for research because of
the very large volumes of information which naturally
accrue and, unlike paper-based records, are accessible
without prohibitively time-consuming data entry. Consid-
ering volume of information, there is a major distinction
between databases using only structured fields, and those
using the free text [13, 14]. Structured data such as age,
sex, diagnosis, and dates of service-level events (admis-
sions, discharges, etc.) are routinely entered by clinical or
administrative staff, can be made readily available for
research use, and are relatively easily de-identified for data
governance requirements. However, the fact that structured
information is more readily available for analysis does not
make it any more valid or accurate than unstructured
information. Clinical uncertainties can be poorly translated
into codes [15–17], and the sustainability of imposed
structured data entry in routine clinical care (e.g. through
embedded checklists and scales in the EHR) remains to be
established. Free text is typically extensive in case note
fields and uploaded correspondence for mental health
EHRs, but less accessible for analysis, and less easily
anonymised; however, text-contained information is
potentially the most valuable for research despite the
inconvenience of having to design mechanisms for
extracting the information.
To make better use of the whole record, text mining
tools have attracted increasing interest as a means of
facilitating research with free text alongside the structured
record [18–21]. This can increase sensitivity for record
identification; for example, Vanderbilt University Medical
Centre found that extraction of diagnosis of dementia from
structured fields identified 38 % of cases found by manual
notes review, whereas 91 % of these were identified
through a free text information extraction application [22].
However, it should be noted that even searching the free
text for a diagnosis will only give an accurate indication of
the numbers of people identified with a disorder, which
may be a substantial underestimate of community cases.
For example, Mayo Clinic analyses found that, of people
identified in research studies as having definite dementia or
autism spectrum disorder, around 70 and 50 %, respec-
tively, had any note of such in their EHR [23, 24].
A key potential advantage of using information derived
from EHR free text is the quantity of phenotypic data
beyond a diagnosis, both in terms of patients’ mental
health—such as symptom profile [25] or treatment
responsiveness [26]—and the context in which a disorder is
occurring [27]. This can be used for highlighting patients
who have inclusion criteria for recruitment into observa-
tional or interventional studies, or can be used to investi-
gate treatment response directly within the database: all
relevant for the development of personalised medicine
[28, 29]. Furthermore, phenotypic signatures of direct
clinical relevance, such as ‘‘high suicide risk’’ or ‘‘vul-
nerable to depression’’, might be fed back in real time via
the EHR to alert the treating clinician [30, 31], coupled
with decision support software or information resources.
Free text can also be mined to define groups or outcomes
that are too rare to be studied conventionally—such as the
use of Khat in South-East London [32] or neuroleptic
malignant syndrome [33].
Primary Care EHRs are potentially valuable for inves-
tigating the wider health of people with common or severe
mental illnesses. Examples include Canadian longitudinal
research into changes in the diagnosis and treatment of
depression [34, 35], or the use of a UK general practice
database to investigate the risk of cardiovascular disease in
people with severe mental illness and to derive a risk
prediction model for this outcome [36]. While some
countries benefit from large healthcare providers with
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associated data resources (e.g. National Health Service data
in the UK, and the Taiwan National Health Insurance
Research Database), others, such as the USA, have brought
together healthcare providers in ‘virtual networks’ [37, 38].
Anonymised data derived from each provider’s EHRs can
be brought together with tools such as the Health Care
Systems Research Network’s online integration tool
‘‘PopMedNet’’ for research, or to compare practices, such
as the benchmarking of psychotropic prescribing [39].
There are also EHR-genomic consortia, such as eMerge—a
collaboration of Marshfield, Mayo Clinic, Northwestern,
Group Health and Vanderbilt—which hosts some dementia
cohorts [40].
It is important that the governance of these EHR data-
bases and projects is planned to balance the concerns of
patients and the needs of researchers. Full anonymization
may not be possible for projects requiring phenotypic
details [41]; other protections such as limited access and
firewalls must therefore be considered so as not to lose
‘‘social licence’’ for these types of projects [42–44]. Both
researchers and patients should have input to the next
generation of data repositories and projects to shape them
towards the kinds of questions that remain outstanding,
such as capturing traits as well as diseases for research
compatible with the USA’s National Institute of Mental
Health Research Domain Criteria (RDoC) paradigm
[45, 46].
Case registers involving de novo data collection
Specialist databases form registries of people in contact
with the mental health system, or have evolved from this to
offer surveillance of both service users and the services
themselves [6]. While it is possible to create and maintain
such a register solely with electronic health records, many
involve the collection of specific data, usually requested
from the service providers. These databases are a helpful
resource for research into patterns of service use and their
individual and societal determinants. Some databases, such
as the Mental Health National Outcomes and Casemix
Collection in Australia and the DGPPN-BADO in Ger-
many have made efforts to include valid measures of out-
come for service users, which helps them monitor
improvement [47, 48] and also for research, such as into
treatments for depression in Germany. There are also
examples of more specialised registries: a database in the
Netherlands recording seclusion and restraint episodes
looking for insights to drive service improvement [49]; and
the GRiST mental health data set in the UK, which deals
with risk assessment and aims to use the data to become a
decision support tool [50, 51].
Administrative databases
We identified a number of examples of projects making
secondary use of large-volume administrative data to draw
conclusions about healthcare use through diagnoses on
hospital discharge notifications, billing for procedures, or
prescriptions. Some of these databases are long established,
such as the Swedish population-based registers; while the
expansion of Medicaid, and the requirement for billing
with ICD-codes, combined with incentives for ‘‘meaning-
ful use’’ of information technology [52], has led to large
accumulations of new data resources. This information
tends to be used to describe treated prevalences of disor-
ders, patterns of prescribing, and comparisons of ‘real-
world’ treatment with recommendations. Where data
include both prescriptions and incident diagnosis, this can
also be useful in pharmacovigilance, using retrospective
cohort or nested case–control studies to investigate adverse
events [53], such as differences in the safety of different
antipsychotics in older patients examined using Medicaid
billing data for nursing home residents [54]. Such data can
also be used to describe treatment costs—which may have
a specific focus, such as a US investigation of the cost of
non-compliance in bipolar disorder [55], or a broader
scope, such as an EU project investigating whether the
financing of health services in different EU countries
affects the quality of mental healthcare [56].
Surveys and biobanks
In most circumstances, surveys and interviews are not
practical for assembling big data resources; however, the
WHO Global Burden of Disease programme uses stan-
dardised mental health surveys (based on the Composite
Diagnostic Interview—CIDI) carried out at intervals by
local research teams in member countries [57], and could
be claimed to come closest to being a ‘big data’ survey in
the mental health field. Large samples have also been
achieved by some biobanks, such as UK Biobank, which
already has self-report data for 500,000 [58] and is looking
to improve its mental health phenotyping through an online
questionnaire based on the CIDI-short form. Genome Wide
Association Studies (GWAS) for complex disorders require
large independent datasets of genomes, therefore it makes
sense for researchers on projects such as UK Biobank to
co-operate with others. The international Psychiatric
Genomics Consortium (PGC) is a means to achieve this,
sharing both datasets and expertise [59]. International
research collaborations have also allowed the leveraging of
neuroimaging taking place in different locations through
the ENIGMA program [60].
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Record linkage
All of the above databases can be given new dimensions
when data from other sources are linked at the level of the
individual [3, 9]. This is facilitated in countries with a
unique identification number for its residents, such as many
of the Nordic countries: for example, allowing researchers
using Sweden’s population-based registers to link reports
of death by suicide to records of psychiatric and medical
diagnoses, periods of sickness absence from work, and
unemployment [61–65]. Danish records that link also to
parents and siblings have been used to investigate potential
risk factors for schizophrenia, such as family history, sea-
son of birth, urban living, and trauma to mother during
pregnancy [66–68]. A number of observational studies
have investigated the safety of psychotropic medication in
pregnancy, but in Western Australia this approach has been
taken one step further by assembling and following an
e-cohort of children born to mothers who have
schizophrenia, using health and social service administra-
tive registers alone; associations with obstetric complica-
tions and subsequent intellectual disability have already
been reported [69, 70].
Data veracity
Although it might be assumed that cohorts assembled
through researcher interviews are preferable to those
derived from administrative data, it is important to recog-
nise that each research method has strengths and limita-
tions. Research interviews do provide potentially highly
accurate information about a person’s status at a particular
time; however, conventional research projects are limited,
and not just in the numbers of cases who can be inter-
viewed and examined. They may also poorly capture
variability or trajectories in health status over time (espe-
cially as recollection of episodes of mental disorder has
been found to be so poor [71]) which may be better char-
acterised from administrative data than retrospective
interview. Furthermore, even highly trained interviewers
might have difficulty ascertaining phenomena like physical
signs or relatively rare symptoms, which may be better
identified from clinician-derived text in health records.
Conversely, as previously discussed, a veracity chal-
lenge for all healthcare databases is that information used
has not, generally, been collected for research reasons;
therefore, data are vulnerable to influence from forces other
than the underlying patterns of disease, and hence the
incentives for record-keeping need to be taken into account
(sometimes considered under a ‘data provenance’ heading).
One important issue concerns diagnosis, as many studies
rely on recorded diagnostic information and frequently do
not have any further information on the disorder under
investigation beyond this. However, many mental disorders
do not result in a documented diagnosis because the person
does not report the disorder to a healthcare practitioner,
because the practitioner does not identify the disorder, or
because they do not assign or record a diagnosis. For
example, in 2009 it was estimated that one-third of all
people living in England with dementia had received a
formal diagnosis [72]. Since then, political pressure,
availability of medication and other factors have changed
the culture surrounding the making and recording of a
dementia diagnosis. Registers of people with dementia kept
by all GPs in primary care have consequently been
increasing in size by an average of 8 % per year [73]—a
change that does not reflect changing epidemiology of the
disease. Primary Care diagnosis rates of anxiety and
depression in the UK have also been found not to be rep-
resentative of disease trends [74, 75]; however, a team at
the Secure Anonymised Information Linkage Databank in
Wales found that combining diagnosis and symptom terms
appeared to be more reflective, which suggests the wisdom
of working with people who are familiar with the data
source being used [76].
Conclusion
Big data are being used for mental health research in
many parts of the world, and for many different purposes.
Secondary use of administrative data, especially where
routine diagnostic information is included, is likely to
become increasingly adopted for research as these infor-
mation resources are relatively inexpensive and scalable.
Furthermore, secondary use of clinical information is
coming up fast behind. ‘Volume’ challenges can generally
be addressed with current information storage capacity
and availability. The ‘velocity’ challenge is yet to be
addressed because most of these big data resources are
static and updated periodically, with few ‘real-time’
applications currently developed; however, this situation
will change if decision support applications are imple-
mented, and/or if learning and artificial intelligence begin
to be incorporated in records systems. ‘Variety’ and
‘variability’, like velocity, are not current challenges but
are likely to become increasingly salient in the near
future. ‘Veracity’ remains a key consideration and one
which is unlikely to change with technological advances,
because secondary data use continues to depend on the
data actually being recorded in clinical practice. The other
big considerations are data governance and security,
which clearly require robust planning and an effective,
ongoing public dialogue.
An over-arching conclusion from this review is that
research questions continue to be shaped by the
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information that happens to be available and accessible in
these data resources. For example, the fact that healthcare
databases are used so extensively for medication-oriented
research questions is likely to reflect the relative ease with
which medication data can be extracted. Equally their lack
of use for investigations of symptom profiles or illicit
substance use reflects the lack of structured data on these
constructs in most records systems. A transition is likely to
be needed whereby the data resources themselves are
shaped, at least to some extent, by research priorities;
however, this is only likely to be effective if the research
priorities, in turn, are shaped by the needs of clinical ser-
vices and those who use them.
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